4.6 Article

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years

期刊

THORAX
卷 73, 期 5, 页码 414-421

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2017-210722

关键词

-

资金

  1. National Heart, Lung and Blood Institute [R01 HL089897, R01 HL089856]
  2. COPD Foundation
  3. AstraZeneca
  4. Boehringer Ingelheim
  5. Novartis
  6. Pfizer
  7. Siemens
  8. Sunovion
  9. GlaxoSmithKline
  10. NIH [K23HL133438]

向作者/读者索取更多资源

Background Cigarette smoking is the strongest risk factor for COPD. Smoking burden is frequently measured in pack-years, but the relative contribution of cigarettes smoked per day versus duration towards the development of structural lung disease, airflow obstruction and functional outcomes is not known. Methods We analysed cross-sectional data from a large multicentre cohort (COPDGene) of current and former smokers. Primary outcome was airflow obstruction (FEV1/FVC); secondary outcomes included five additional measures of disease: FEV1, CT emphysema, CT gas trapping, functional capacity (6 min walk distance, 6MWD) and respiratory morbidity (St George's Respiratory Questionnaire, SGRQ). Generalised linear models were estimated to compare the relative contribution of each smoking variable with the outcomes, after adjustment for age, race, sex, body mass index, CT scanner, centre, age of smoking onset and current smoking status. We also estimated adjusted means of each outcome by categories of pack-years and combined groups of categorised smoking duration and cigarettes/day, and estimated linear trends of adjusted means for each outcome by categorised cigarettes/day, smoking duration and pack-years. Results 10 187 subjects were included. For FEV1/FVC, standardised beta coefficient for smoking duration was greater than for cigarettes/day and pack-years (P<0.001). After categorisation, there was a linear increase in adjusted means FEV1/FVC with increase in pack-years (regression coefficient beta=-0.023 +/- SE0.003; P=0.003) and duration over all ranges of smoking cigarettes/day (beta=-0.041 +/- 0.004; P<0.001) but a relatively flat slope for cigarettes/day across all ranges of smoking duration (beta=-0.009 +/- 0.0.009; P=0.34). Strength of association of duration was similarly greater than pack-years for emphysema, gas trapping, FEV1, 6MWD and SGRQ. Conclusion Smoking duration alone provides stronger risk estimates of COPD than the composite index of pack-years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据